N²,N⁴,N⁶-Tris-(1,1,3,3-tetramethylbutyl)-melamin | 21840-38-0

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 三嗪类
• 英文名称: N²,N⁴,N⁶-Tris-(1,1,3,3-tetramethylbutyl)-melamin
• 英文别名: N,N',N''-tris-(1,1,3,3-tetramethyl-butyl)-[1,3,5]triazine-2,4,6-triamine；n,n',n''-Tris(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4,6-triamine；2-N,4-N,6-N-tris(2,4,4-trimethylpentan-2-yl)-1,3,5-triazine-2,4,6-triamine
• CAS: 21840-38-0
• 化学式: C₂₇H₅₄N₆
• 分子量: 462.766
• InChiKey: DBUFHHJVYLAZLZ-UHFFFAOYSA-N

物化性质

• 沸点：
  546.7±33.0 °C(Predicted)
• 密度：
  0.975±0.06 g/cm3(Predicted)

计算性质

• 辛醇/水分配系数(LogP)：
  9
• 重原子数：
  33
• 可旋转键数：
  12
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.89
• 拓扑面积：
  74.8
• 氢给体数：
  3
• 氢受体数：
  6

反应信息

• 作为产物：
  描述：

  2-chloro-4,6-bis(1,1,3,3-tetramethylbutylamino)-1,3,5-triazine 、 叔辛胺 、 2-羟基吡啶 、 sodium hydroxide 在 乙醇 作用下， 反应 2.0h， 以of a beige solid is obtained m.p. 151°-156° C的产率得到N²,N⁴,N⁶-Tris-(1,1,3,3-tetramethylbutyl)-melamin
  参考文献：
  名称：

  Method of treating arthritic disease

  摘要：

  本公开说明了一些物质组成，作为抗炎剂和抑制关节退化特征的关节炎疾病的进展的抑制剂，并描述了使用这些物质组成物来改善哺乳动物的炎症和抑制关节退化的方法，该物质组成物的活性成分是某些2-（取代氨基）-4,6-双（烷基氨基）-s-三嗪。

  公开号：

  US04269832A1

文献信息

• [EN] DEGRADABLE MATERIAL<br/>[FR] MATÉRIAU DÉGRADABLE
  申请人：BASF SE

  公开号：WO2009135813A1

  公开（公告）日：2009-11-12

  A composition containing the components (A), (B-I) and (B-Il) wherein component (A) is an organic polymer; component (B-I) is an amine derivative of the formula (I) N(X1)(X2)(X3) wherein X1 is C8-C36alkyl or C8-C36alkenyl; X2 is hydrogen, C1C36alkyl, C2-C36alkyl substituted by 1, 2 or 3 radicals selected from the group consisting of -OH and -N(Y11)(Y12); C8-C36alkenyl or C5-C8cycloalkyl; or X1 and X2, together with the nitrogen atom, form morpholino; X3 is C1C36alkyl, C2-C36alkyl substituted by 1, 2 or 3 radicals selected from the group consisting of -OH and -N(Y11)(Y12); C8-C36alkenyl, C5-C8cycloalkyl or a group of the formula (a) or the radicals X2 and X3 form together a group of the formula (b), (c) or (d) Y11 and Y12 are independently of one another hydrogen, C8-C36alkyl or C2-C36hydroxyalkyl; Y21 and Y22 are independently of one another a group -N(Y11)(Y12) or morpholino; Y31 is C8-C36alkyl or C8-C38alkenyl; Y41 and Y42 are independently of one another C8-C36alkyl or C8-C38alkenyl; Y51 is C8-C36alkyl or C8-C36alkenyl; if X2 and X3 form together a group of the formula (d), X1 can additionally be C2-C36hydroxyalkyl; and component (B-Il) is an inorganic or organic salt of a transition metal.